CONCLUSIONS
This is the first study on the prevalence of DIC and associated genetic
biomarker predictive evaluation in Zimbabwean breast cancer patients.
The genetic frequencies observed in our study was different to that
reported in other populations. A larger sample size with a longer follow
up time will be necessary in future studies.